Prognostic significance of Ki67 labelling in resected non small cell lung cancer
- 31 December 1993
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 29 (3), 363-365
- https://doi.org/10.1016/0959-8049(93)90387-u
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Growth fraction in lung tumours determined by Ki67 immunostaining and comparison with agnor scoresThe Journal of Pathology, 1990
- Ki67 immunostaining in primary breast cancer: pathological and clinical associationsBritish Journal of Cancer, 1989
- Cell cycle dependent distribution of the proliferation-associated Ki-67 antigen in human embryonic lung cellsVirchows Archiv B Cell Pathology Including Molecular Pathology, 1988
- Flow cytometric analysis of DNA ploidy level in paraffin-embedded tissue of non-small-cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- The New International Staging System for Lung CancerSurgical Clinics of North America, 1987
- The Use of the Monoclonal Antibody Ki-67 in the Identification of Proliferating Cells: Application to Surgical NeuropathologyThe American Journal of Surgical Pathology, 1986
- Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.Journal of Clinical Pathology, 1986
- Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinomaCancer, 1985
- Histological Typing of Lung TumoursTumori Journal, 1981
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981